The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001363576.1:c.686del

CA2573332225

Gene: IDUA (HGNC:3425)
Condition: mucopolysaccharidosis type 1 (MONDO:0001586)
Inheritance Mode: Autosomal recessive inheritance
UUID: 84b6fe98-c34a-46c9-bae5-bb95f5e632aa
Approved on: 2025-01-03
Published on: 2025-01-03

HGVS expressions

NM_001363576.1:c.686del
NC_000004.12:g.1002378del
CM000666.2:g.1002378del
NC_000004.11:g.996166del
CM000666.1:g.996166del
NC_000004.10:g.986166del
NG_008103.1:g.20382del
ENST00000247933.9:c.1082del
ENST00000514224.2:c.1082del
ENST00000652070.1:n.1138del
ENST00000247933.8:c.1082del
ENST00000514224.1:c.686del
ENST00000514698.5:n.1189del
NM_000203.4:c.1082del
NR_110313.1:n.1170del
NM_000203.5:c.1082del
More

Likely Pathogenic

Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Diseases Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for IDUA Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000203.5:c.1082del (p.Ala361GlyfsTer79) variant in IDUA is a frameshift variant predicted to cause a premature stop codon in exon 9 out of 14 total exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent in gnomAD v4.1.0. To our knowledge, this variant has not been reported in the literature in any individuals with mucopolysaccharidosis type 1. The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ). In summary, this variant meets the criteria to be classified as likely pathogenic for mucopolysaccharidosis type 1. IDUA-specific ACMG-AMP criteria applied, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 1.0.0): PVS1, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on January 3, 2025)
Met criteria codes
PVS1
The NM_000203.5:c.1082del (p.Ala361GlyfsTer79) variant in IDUA is a frameshift variant predicted to cause a premature stop codon in exon 9 out of 14 total exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PM2_Supporting
This variant is absent in gnomAD v4.1.0.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.